Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial

From the Herbs and Mental Health Library

Available with CNP Library Membership

Join the CNP Research Library to unlock this summary and 3,000+ others across five population libraries.

View membership plans

Related Studies

Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in Schizophrenia: A randomized, double-blind, placebo-controlled study

The objective in this study by Chengappa et al. (2018) was to determine if adjunctive therapy with a standardized extract of withania somnifera (WSE) — which has known anti-inflammatory and immunomodulating properties — can improve psychopathology and stress in sufferers of schizophrenia or schizoaffective disorder. In this randomly-assigned, double-blind, placebo-controlled study, 66 patients with exacerbating […]

Efficacy and safety of Ashwagandha (Withania somnifera) root extract in Insomnia and anxiety: A double-blind, randomized, placebo-controlled study

Since “most of the currently available drugs for insomnia exert adverse effects,” Langade et al. (2019) set out to test the efficacy and safety of ashwagandha root extract in patients with insomnia and anxiety. The double-blind, randomized study was conducted at Prakruti Hospital in Maharashtra, India. It included 60 patients who were randomly assigned to […]